Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
There is a high prevalence of smoking among people with schizophrenia, and there are few
smoking treatment programs for these smokers. The aims of this study are to investigate the
separate and combined effects of bupropion and a voucher incentive program on smoking in
people with schizophrenia.